The epidemiology of systemic lupus erythematosus

https://doi.org/10.1016/0049-0172(73)90034-6Get rights and content

Abstract

The present review has focused on the methods and results of epidemiological studies of SLE for clues to its etiology based on reports of the occurrence of SLE in the general population and on the conditions under which it is likely to occur. The review covers the period from 1950 to 1972, and is limited to idiopathic SLE.

Reports of population studies on SLE were published from four widely scattered regions, namely, New York City; Jefferson County, Alabama; Rochester, Minnesota; and Malmo, Sweden. Geographic variations in the prevalence of the disorder were observed, which were largely attributed to regional differences in completeness of case finding. The reported crude rates were highest in Rochester, lowest in Jefferson County, and at an intermediate level in Malmo and New York City where the findings were similar.

In New York City, the annual incidence of newly occurring cases of idiopathic SLE from 1956 to 1965 appeared to be stabilized at a level of about 2.5/100,000 general population, while the prevalence of existing cases rose progressively from 4.1 to 15.5 per 100,000 during the same 10-yr period. The even level in incidence trend indicated that the occurrence of SLE was not appreciably influenced by changes in host or environmental conditions during the study period. The steady increase in prevalence was attributed to earlier recognition of the disease and to longer survival because of improved therapy. The annual mortality was roughly half the incidence in the decade 1956–1965.

The specific incidence of the disease by age and sex was usually highest at 15–44 yr of age, while its prevalence was maximal at 45–64 yr. The respective incidence and prevalence rates at these ages were 14.0 and 90.9/100,000 for black females and 3.8 and 27.6 for white females in New York City. The rates among Puerto Ricans appeared to be intermediate between those for blacks and whites. However, some of the evidence on age and SLE pointed to an earlier age-distribution of cases among Puerto Ricans than among blacks or whites.

The risk of SLE was higher for black females than whites in both New York City and Jefferson County, Alabama, according to cooperative studies there. In males, however, the comparative results on ethnic differences in the occurrence of SLE were conflicting and inconclusive because of the small number of cases in each area.

The higher rates of SLE for blacks and Puerto Ricans could not be related to more complete case finding or to unfavorable environmental conditions in low socioeconomic groups. On the other hand, the results appeared to be related to underlying ethnic differences in immune mechanism, according to studies on serum gamma globulin level and Mantoux reaction to BCG in normal subjects.

Familial studies revealed some evidence of an increase in serum gamma globulin, and possibly in antinuclear factor and other SLE-related immunological and clinical abnormalities among first-degree relatives of SLE cases. The findings were indicative of a demonstrable familial or a genetic influence in the occurrence of the disorder. The abnormalities were mainly concentrated in selected families, and environmental factors could not be excluded. However, the occurrence of the disease was found to be independent of birth order, an indication that it represents a random event consistent with genetic factors and unrelated to change with time in parity, parental age, and related environmental influences.

More direct evidence for genetically determined host factors in the predisposition to SLE has been sought in studies on the relationship of the disorder to the histocompatibility (HL-A) antigens which may be closely linked to the activity of the immune mechanism. Thus far, different specific HL-A antigens, viz., A5, A7, A8, A13, W5, W15, and an X type, were observed by various investigators in association with SLE and the risk of developing the disease. Whether these diverse findings have biological significance or are artifacts attributable to chance and other factors unrelated to SLE is still not known.

In the predisposed subject, each of the three broad groups of environmental agents, namely, physical, chemical, and biologic, has been associated with SLE. The relationship of the disorder to physical agents such as ultraviolet radiation and trauma has been well documented in past clinical experiences. The association of SLE and chemical agents described in early clinical reports on inducing factors has been strengthened by many studies on procainamide, hydralazine, and other drugs responsible for an increased frequency of drug-induced SLE. Interest in the role of biological agents has been renewed by reports on increased antibody levels for paramyxovirus and other viral antigens in affected patients, and the detection of cellular inclusions resembling paramyxoviruses in cases of SLE and other disorders. Whether these widespread findings in man are coincidental manifestations of SLE or evidence of persistent virus infections that may be responsible for the disease has not yet been ascertained.

In animals, however, support for the role of viral and genetic factors in the pathogenesis of SLE has been well documented in the susceptibility of inbred NZB/NZW mice to SLE-like disorders, and the identification of a virus-like agent in the affected NZB mice. In susceptible dogs, also, SLE-like manifestations appear to be due to genetic and nongenetic factors, presumably of viral origin.

References (100)

  • ER Hurd et al.

    Cytoplasmic tubular structures in kidney biopsies in patients with systemic lupus erythematosus (SLE) and in patients with various renal diseases

    Arthritis Rheum

    (1970)
  • HA Silverman et al.

    Demonstrations of microtubular inclusions in cell cultures of systemic lupus erythematosus (SLE) skin

    Arthritis Rheum

    (1972)
  • AW Helder et al.

    Microtubules of systemic upus erythematosus

    Lancet

    (1971)
  • PM Feorino et al.

    Viral isolation studies of inclusion positive biopsy from human connective tissue diseases

    Arthritis Rheum

    (1970)
  • PE Phillips et al.

    Myxovirus antibody increases in human connective tissue disease

    Science

    (1970)
  • DA Stevens et al.

    Epstein-Barr virus (herpes-type virus) antibodies in connective tissue diseases

    Arch Intern Med

    (1972)
  • JF Ziegenfuss et al.

    Correspondence

    Lancet

    (1972)
  • CJ Lucas et al.

    Measles antibodies in sera from patients with autoimmune diseases

    Lancet

    (1972)
  • PH Schur et al.

    Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases

    Arthritis Rheum

    (1971)
  • McG A Harvey et al.

    Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases

    Medicine

    (1954)
  • M Siegel et al.

    The epidemiology of systemic lupus erythematosus. Results of a population study in New York City

  • Preliminary criteria for the classification of systemic lupus erythematosus

    Bull Rheum Dis

    (1971)
  • M Siegel et al.

    Epidemiologie studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956–1965

    Arth Rheum

    (1970)
  • LT Kurland et al.

    Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951–1967, with special reference to systemic lupus erythematosus

  • A Svanborg et al.

    Incidence of disseminated lupus erythematosus. Follow-up studies indicating increased frequency

    JAMA

    (1957)
  • T Leonhardt

    Family studies in systemic lupus erythematosus

    Acta Med Scand

    (1964)
  • EL Dubois

    Lupus Erythematosus. A Review of the Current Status of Discoid and Systemic Lupus Erythematosus and Their Variants

    (1966)
  • DL Larson

    Systemic Lupus Erythematosus

    (1961)
  • LA Brunsting

    Disseminated (systemic) lupus erythematosus

  • M Siegel et al.

    Racial and social factors in systemic lupus erythematosus

    JAMA

    (1965)
  • RK Maddock

    Incidence of systemic lupus erythematosus by age and sex

    JAMA

    (1965)
  • RC Mellors et al.

    Immunopathology of NZB/BL mice, V. Viruslike (filterable) agent separable from lymphoma cells and identifiable by electron microscopy

    J Exp Med

    (1966)
  • M Siegel et al.

    Racial differences in serum gamma globulin levels: Comparative data for Negroes, Puerto Ricans and other Caucasians

    J Lab Clin Med

    (1965)
  • M Siegel et al.

    Racial differences in Mantoux reaction after BCG vaccination: Implications in systemic lupus erythematosus

    Am Rev Resp Dis

    (1968)
  • D Gitlin et al.

    Gammaglobulins and their clinical significance. 1. Chemistry, immunology and metabolism

    N Engl J Med

    (1959)
  • HM Rawnsley et al.

    Serum protein concentration in the North American Negroid

    Science

    (1956)
  • VE Pollak et al.

    Observations on electrophoresis of serum proteins from healthy North American Caucasian and Negro subjects and from patients with systemic lupus erythematosus

    J Lab Clin Med

    (1961)
  • GC Klein et al.

    Differences between the normal serum protein patterns of American Indian, Negro and Caucasian subjects

  • MA Lichtman et al.

    The distribution of the serum immunoglobulins, antigamma G globulins (“rheumatoid factors”) and antinuclear antibodies in white and Negro subjects in Evans County, Georgia

    Arth Rheum

    (1967)
  • RA Goldstein et al.

    Effect of race and stage of disease on the serum immunoglobulins in sarcoidosis

    JAMA

    (1969)
  • RM Cass et al.

    Immunoglobulins G, A and M in systemic lupus erythematosus. Relationship to serum complement titer, latex titer, antinuclear antibody and manifestations of clinical disease

    Ann Intern Med

    (1968)
  • M Allansmith et al.

    The influence of heredity and environment on human immunoglobulin levels

    J Immunol

    (1969)
  • AT Masi et al.

    Epidemiologic study of Hashimoto's disease

    Arthritis Rheum

    (1963)
  • SR Block et al.

    Studies of delayed hypersensitivity in systemic lupus erythematosus

    Ann Rheum Dis

    (1968)
  • T Bitter et al.

    In vivo and in vitro study of cell-mediated immunity during the onset of systemic lupus erythematosus

    Arthritis Rheum

    (1971)
  • JA Goldman et al.

    Cellular immunity to nuclear antigens in systemic lupus erythematosus

    Arthritis Rheum

    (1971)
  • M Ziff

    Viruses and the connective tissue diseases

    Ann Intern Med

    (1971)
  • AT Masi et al.

    Epidemiology of fatal systemic sclerosis (diffuse scleroderma)

    Ann Intern Med

    (1967)
  • JS Lawrence et al.

    Rheumatoid arthritis in a subtropical population

    Ann Rheum Dis

    (1966)
  • J Baum et al.

    The rarity of ankylosing spondylitis in the black race

    Arthritis Rheum

    (1970)
  • Cited by (0)

    1

    From the Department of Environmental Medicine and Community Health, State University of New York, College of Medicine at New York City.

    2

    From the Department of Medicine, Jewish Hospital and Medical Center of Brooklyn, New York.

    View full text